Pharma and Biotech
Chief Executive Officer : | Lisa Anson |
Independent Non-Executive Director: | Bernhard Kirschbaum |
Independent Non-Executive Director: | Peter Presland |
Independent Non-Executive Director: | Rob Scott |
Non-Executive Chairman: | Jane Griffiths |
Non-Executive Dir: | Joseph Anderson, Natalie Berner |
Address: | Block 33, Mereside, Alderley Park, United Kingdom, SK10 4TG |
Phone: | +44 (0)1625 469900 |
Website: | http://redxpharma.com |
Sector: | Pharma and Biotech(LSE) |
ISIN: | GB00BSNB6S51 |
Currency | UK Pounds |
Share Price | 12.00p |
Change Today | -0.75p |
% Change | -5.88 % |
52 Week High | 36.00 |
52 Week Low | 4.25 |
Volume | 582,013 |
Shares Issued | 388.99m |
Market Cap | £46.68m |
RiskGrade | 278 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:27 | 150,000 @ 11.90p |
16:18 | 90,000 @ 11.61p |
16:35 | 221,630 @ 12.00p |
16:35 | 50,000 @ 12.00p |
16:35 | 256 @ 12.00p |
You are here: research